Key result
Implantation of a cardiac contractility modulation device in a 28-year-old male with mixed dilated cardiomyopathy led to significant clinical and echocardiographic improvement over 4 years.
Case Report (n=1)
Cardiac contractility modulation may provide long-term clinical and echocardiographic stabilization in young patients with mixed dilated cardiomyopathy and severe heart failure.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for long-term CCM benefit in young mixed DCM; prospective trials needed before clinical adoption.
The article presents a case report of a 28-year-old male patient with mixed dilated cardiomyopathy: myocardial noncompaction and chemotherapy-related cardiotoxicity, which led to severe heart failure (HF). With optimal drug therapy, the patient was implanted with a cardiac contractility modulation device in order to improve exercise tolerance, quality of life and relieve HF symptoms. Complex therapy has led to significant clinical and echocardiographic improvement. This case demonstrates a 4-year follow-up of a patient with a reduced left ventricular ejection fraction and an implanted cardiac contractility modulation device, whose condition, after several severe HF decompensations, was stabilized.
No takes yet. Share an insight, caveat, or question.
Uskach et al. (2021) conducted a case report in Mixed dilated cardiomyopathy and severe heart failure (n=1). Cardiac contractility modulation device was evaluated on Clinical and echocardiographic improvement. Implantation of a cardiac contractility modulation device in a 28-year-old male with mixed dilated cardiomyopathy led to significant clinical and echocardiographic improvement over 4 years.
Synapse has enriched 10 related papers. Consider them for comparative context: